Triveni Bio develops first-in-class antibody therapeutics for immunological and inflammatory disorders using a genetics-informed approach.
SunFire Biotechnologies: A contract research organization specializing in vaccine evaluation.
Los Angeles-based medical organization developing therapeutic antibodies.
Hinge Bio, Inc.: A private biotech firm innovating in infectious disease and oncology via its GEM-DIMER™ platform.
NKA Bio: Innovating trauma care with medical devices for resuscitation and shock treatment.
Rondo Therapeutics: Developing novel bispecific antibodies to combat cancer, since 2021.
Origen Therapeutics: A California-based biotech firm specializing in human sequence polyclonal antibodies.
Planet Biotechnology: A US-based clinical-stage company developing antibody-based therapeutic products.
IDBiologics: Pioneering infectious disease treatment through rapid discovery and optimization of human monoclonal antibodies.
RevMAb Biosciences: Innovating in biotech for superior disease diagnosis with unique monoclonal antibodies.
Philadelphia-based Integral Molecular is a biotech firm innovating therapeutic antibodies and technologies.
Discover cancer-fighting bispecific antibodies with LiliumX's protein technology platform.
Crystal Bioscience develops diverse therapeutic antibodies using a unique chicken-based discovery engine.
Apriori Bio: Innovating in vaccine and antibody technology for global viral protection.
Ingenia Therapeutics: A biotech startup developing therapeutic antibodies for cancer and chronic diseases.
PhylloTech, a US-based company, innovatively uses plants to produce cost-effective proteins and antibodies, offering rapid scalability and environmental sustainability.
Sialix Cancer Research: Providing cancer antibodies and innovative laser-based diagnostic solutions.
US-based Vaccinex, Inc. develops therapeutic antibodies and vaccines for cancer, neurodegenerative diseases, and autoimmune disorders.
Seattle-based Theraclone Sciences develops innovative therapeutic antibodies for infectious diseases and inflammation.
SBI: A US-based biotech firm specializing in synthetic antibody technology and therapeutic peptides.
XBiotech Inc., a US-based clinical-stage biopharmaceutical firm, develops antibodies for diverse diseases.
Leading development of anti-CD70 antibodies for cancer treatment.
US-based ImmuneXcite enhances therapeutic monoclonal antibodies' efficacy with its platform technology.
Pamlico BioPharma develops human monoclonal antibodies for rapid diagnosis and treatment of diseases and cancer.
ABclonal: Global supplier of antibody, molecular enzyme reagents in biotechnology.